Table 1 Clinical and immunohistochemical features of AFX and BFH
From: Mutation analysis of the Gadd45 gene at exon 4 in atypical fibroxanthoma
| Lesion | Age/Sex/Location | Bax | Gadd45* | Gadd45 mutation at exon 4 | p53* |
|---|---|---|---|---|---|
| A3 AFX | 82/M/Scalp | - | - | NA | - |
| A7 AFX | 84/M/Face | - | + | - | - |
| A10 AFX | 65/M/Auricle | - | - | - | + |
| A14 AFX | 71/M/Auricle | + | + | - | + |
| A16 AFX | 50/M/Finger | - | - | - | - |
| A17 AFX | 46/M/Finger | + | + | - | - |
| A19 AFX | 64/F/Leg | + | + | - | - |
| B8 BFH | 18/F/Thigh | - | - | NA | - |
| B9 BFH | 38/F/Back | - | - | NA | - |
| B12 BFH | 32/M/Thigh | - | - | NA | - |
| B13 BFH | 35/F/Leg | - | + | NA | - |
| B16 BFH | 30/F/Chest wall | - | - | NA | - |
| B17 BFH | 23/M/Forearm | - | - | NA | - |
| B21 BFH | 31/F/Leg | - | - | NA | - |